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The organic anion transporter SLCO2A1 constitutes an essential core component of the
ATP-conductive large-conductance anion (Maxi-Cl) channel. Our previous experiments
using Langendorff-perfused mouse hearts showed that the Maxi-Cl channel contributes
largely to the release of ATP into the coronary effluent observed during 10-min
reperfusion following a short period (6 min) of oxygen-glucose deprivation. The present
study examined the effect of endogenous ATP released via Maxi-Cl channels on the left
ventricular contractile function of Langendorff-perfused mouse hearts, using a fluid-filled
balloon connected to a pressure transducer. After the initial 30-min stabilization period,
the heart was then perfused with oxygen-glucose-deprived Tyrode solution for 6 min,
which was followed by a 10-min perfusion with oxygenated normal Tyrode solution in the
absence and presence of an ATP-hydrolyzing enzyme, apyrase, and/or an adenosine
A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX). In the absence of
apyrase and DPCPX, the left ventricular developed pressure (LVDP) decreased from a
baseline value of 72.3 ± 7.1 to 57.5 ± 5.5 mmHg (n = 4) at the end of 6-min perfusion
with oxygen-glucose-deprived Tyrode solution, which was followed by a transient
increase to 108.5 ± 16.5 mmHg during subsequent perfusion with oxygenated normal
Tyrode solution. However, in the presence of apyrase and DPCPX, the LVDP decreased
to the same degree during 6-min perfusion with oxygen-glucose-deprived Tyrode
solution, but failed to exhibit a transient increase during a subsequent perfusion with
oxygenated normal Tyrode solution. These results strongly suggest that endogenous
ATP released through Maxi-Cl channels contributes to the development of transient
positive inotropy observed during reperfusion after short-period hypoxia/ischemia in
the heart.
Keywords: ATP release, endogenous ATP, ischemia-reperfusion, left ventricular contractile function, maxi-anion
channel, Langendorff perfusion, mouse heart
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INTRODUCTION
During hypoxia or ischemia, ATP is known to be released from
the heart (Paddle and Burnstock, 1974; Forrester and Williams,
1977; Clemens and Forrester, 1981; Williams and Forrester, 1983;
Vial et al., 1987; Borst and Schrader, 1991) and cardiomyocytes
(Borst and Schrader, 1991; Kuzmin et al., 1998, 2000; Dutta et al.,
2004; Kunugi et al., 2011). In neonatal rat cardiomyocytes, it was
demonstrated that ATP is released predominantly through the
maxi-anion channel in response to hypoxia or ischemia (Dutta
et al., 2004; Kunugi et al., 2011). By applying unbiased genome-
wide approaches and by using targeted siRNA screening and
CRISPR/Cas9-mediated knockout, we recently demonstrated
that the organic anion transporter SLCO2A1 constitutes the core
component of the maxi-anion channel (Sabirov et al., 2017). In
addition, our experiments using the Langendorff-perfused mouse
heart model showed (i) that the release of ATP into the coronary
effluent is markedly enhanced during 10-min reperfusion after
a short period (6 min) of the oxygen-glucose deprivation, and
(ii) that treatment of the mouse with Slco2a1-targeting siRNA
significantly reduces the release of ATP (Sabirov et al., 2017).
These observations support the view that ATP is released through
the ATP-conductive large-conductance anion (Maxi-Cl) channel
during reperfusion following a short period of hypoxia in the
Langendorff-perfused mouse heart model. The present study was
designed to investigate the effect of endogenous ATP released
during hypoxia/reperfusion on the left ventricular contractile
function of Langendorff-perfused mouse heart model.
Previous studies showed that extracellular application of ATP,
but not ADP, AMP or adenosine, increases the contractility
of rat ventricular myocytes (Danziger et al., 1988) and that
when adenosine receptors were blocked, this exogenously applied
ATP produces a positive inotropic effect in isolated left atria
from guinea-pig (Mantelli et al., 1993). In the present study,
we aimed to examine whether endogenous ATP, but not its
hydrolyzed products, released from the mouse heart during
hypoxia/reperfusion exerts a positive inotropic action.
MATERIALS AND METHODS
Langendorff Perfusion of Mouse Heart
All animal care and experimental procedures were performed in
accordance with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996) and were approved by
the Shiga University of Medical Science Institutional Animal
Care and Use Committee [approval numbers 2015-3-4H, 2016-
7-21(H1), and 2018-11-2]. Female C57BL/6J mice of 8 to
10 weeks (body weight, 16–20 g) were used in the present study,
in the same manner as was reported in our previous study
(Sabirov et al., 2017). The mice were deeply anesthetized with
an overdose of sodium pentobarbital (300 mg/kg, intraperitoneal
injection) with heparin (8,000 U/kg), and the heart was excised
and transferred rapidly to a Langendorff perfusion apparatus
(ADInstruments, Castle Hill, NSW, Australia). Hearts were
perfused with oxygenated (bubbled with 100% O2) normal
Tyrode solution at 37◦C at a constant hydrostatic pressure of
80 mmHg. The normal Tyrode solution contained (in mM) 140
NaCl, 5.4 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.33 NaH2PO4, 5.5 glucose
and 5 HEPES (pH adjusted to 7.4 with NaOH). A fluid-filled
balloon (made of plastic film) connected to a pressure transducer
(ADInstruments) was introduced into the left ventricular cavity
through an opening of the left atrial appendage and inflated
to achieve a left ventricular end-diastolic pressure (LVEDP) of
approximately 5–10 mmHg (Kojima et al., 2018). The pressure
was continuously measured and recorded with PowerLab 8/30
and LabChart Pro-7.0 software programs (ADInstruments).
Hearts were immersed in warmed perfusate in a water-jacketed
organ chamber (approximately 100 ml in volume) maintained at
37◦C (Reichelt et al., 2009).
Experimental Protocols
The Langendorff perfusion protocol was essentially the same
as that used in our previous study for the measurement of
ATP released into the coronary effluent in the mouse heart
(Sabirov et al., 2017). After the initial 30 min of stabilization
with oxygenated normal Tyrode solution, the experiments
were started with following protocols: 6 min of oxygen-
glucose deprivation (OGD) followed by 10 min of reperfusion
with oxygenated normal (glucose-containing) Tyrode solution
(OGD/reperfusion). The OGD treatment was conducted by
perfusing the heart with 100% N2-bubbled Tyrode solution in
which glucose was replaced with an equimolar concentration
of 2-deoxyglucose (Sigma Chemical Company, St. Louis, MO,
United States). In the next set of experiments, we added 1
U/ml of an ATP-hydrolyzing enzyme, apyrase (Sigma), to the
perfusion medium to degrade (remove) ATP, together with
a selective adenosine A1 receptor antagonist, 8-cyclopentyl-
1,3-dipropylxanthine (DPCPX, Sigma), at 10 µM. Apyrase
sequentially catalyzes the breakdown of ATP to AMP, which is
then degraded to adenosine by the action of the endothelial ecto-
5′-nucleotidase (Gündüz et al., 2006). Possible stimulation of the
adenosine A1 receptor is, however, prevented by the presence of
DPCPX under this condition. Apyrase and DPCPX were added
to the perfusion medium 10 min prior to imposition of OGD
and were present throughout the experiment. During the same
time period, apyrase (1 U/ml) or DPCPX (10 µM) was separately
added to the perfusion medium to investigate the functional
basis of ATP action. These perfusion protocols are summarized
in Figure 1. The effect of OGD/reperfusion on the cardiac
function was evaluated by measuring the following parameters:
left ventricular developed pressure (LVDP), calculated by
subtracting left ventricular end-diastolic pressure (LVEDP) from
left ventricular (LV) systolic pressure, and the peak positive and
negative differentials of pressure change with time (+dP/dt and
-dP/dt, respectively). These parameters were evaluated before
and at the end of 6-min OGD, and at 2–5 min and 10 min
after reperfusion.
Statistical Analysis
All of the average data are presented as the mean ± SD, and the
number of experiments is indicated by n. Statistical comparisons
were evaluated using ANOVA with Tukey’s post hoc test (Prism
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FIGURE 1 | Langendorff-perfusion protocol for isolated mouse hearts in the absence (A) and presence of apyrase + DPCPX (B), apyrase alone (C) and DPCPX
alone (D).
Version 5.0; GraphPad Software, La Jolla, CA, United States). We
used two-tailed hypothesis testing for all tests. Differences were
considered to be statistically significant at P < 0.05.
RESULTS
In the present study, we examined the functional effect of
endogenous ATP released upon OGD/reperfusion on the left
ventricular contractile activity, using exactly the same perfusion
protocol as that used by Sabirov et al. (2017). The LV pressure
was measured using an intraventricular balloon as an index of the
left ventricular contractile function. Figure 2A shows continuous
recordings of LV pressure, measured before, during and after
the 6-min OGD. The LV pressure gradually decreased during
6 min of OGD, which was followed by a transient increase
over baseline levels during reperfusion with glucose-containing
oxygenated medium.
We then conducted the same experiments in the concomitant
presence of the ATP-hydrolyzing enzyme apyrase (1 U/ml)
and the selective adenosine A1 receptor antagonist DPCPX
(10 µM). Under these conditions, the released ATP is expected
to be degraded to adenosine (Gündüz et al., 2006), which,
however, cannot stimulate the adenosine A1 receptor. Figure 2B
demonstrates a representative experiment examining the effect
of OGD/reperfusion on LV pressure during the continuous
presence of apyrase and DPCPX. The LV pressure gradually
decreased during OGD, similarly to the decrease observed
in the experiment performed without apyrase and DPCPX
(Figure 2A). However, a transient increase in LV pressure was
largely abolished during reperfusion in the presence of apyrase
and DPCPX. Thus, concomitant addition of apyrase and DPCPX
appears to scarcely affect the gradual decline in LV pressure
observed during OGD but to significantly prevent a transient
increase in LV pressure detected during reperfusion. We also
examined the effect of apyrase and DPCPX added separately
to the perfusion medium during the same time period, and
found that a transient increase in LV pressure upon reperfusion
following OGD appeared in the presence of DPCPX alone but
was abolished in the presence of apyrase alone (data not shown,
n = 4; see Figures 3C, 4C).
We next compared LVDP, measured at various time points
during Langendorff perfusion conducted in the absence and
presence of apyrase and DPCPX (Figure 3). Apyrase and DPCPX,
added together or separately to the perfusion medium, did not
significantly affect LVDP measured before OGD (Figure 3A).
LVDP similarly decreased during 6-min OGD, irrespective of
the presence of apyrase and/or DPCPX (Figure 3B). However,
in the presence of apyrase + DPCPX or apyrase alone, LVDP
measured at 2–5 min after reperfusion was significantly smaller
than that measured without apyrase and DPCPX (Control)
(Figure 3C). On the other hand, LVDP measured at 2−5 min
after reperfusion did not significantly differ between control and
DPCPX groups. There was no significant difference in LVDP
measured at 10 min after reperfusion, irrespective of the presence
of apyrase and/or DPCPX (Figure 3D). These experimental
results indicate that the transient increase in LVDP observed
during 10-min reperfusion after 6-min OGD is ascribable to
ATP itself but not to its hydrolyzed product, adenosine, which
stimulates the adenosine A1 receptors.
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FIGURE 2 | Effects of oxygen-glucose deprivation (OGD) and reperfusion with an oxygenated, glucose-containing solution on the left ventricular function of the
Langendorff-perfused mouse heart model. (A,B) Continuous traces of left ventricular pressure recorded before, during and after 6-min OGD in the absence (A) and
presence (B) of 1 U/ml apyrase and 10 µM DPCPX (upper panels). Lower panels illustrate original traces of left ventricular pressure, recorded at a, b, c, and d in
upper panels, on expanded time scale.
We also evaluated the possible changes in the rate of
contraction and relaxation (as assessed by +dP/dt and -
dP/dt, respectively) at various time points during Langendorff
perfusion in the absence and presence of apyrase and/or DPCPX.
As shown in Figure 4, both +dP/dt and -dP/dt measured
at 2−5 min after reperfusion were significantly smaller in
hearts perfused with apyrase + DPCPX or apyrase alone, in
comparison to those perfused without apyrase and DPCPX
(Control). It should also be noted that addition of DPCPX alone
did not produce any significant effect on +dP/dt and -dP/dt
values measured at 2−5 min after reperfusion. There were no
significant differences in +dP/dt and -dP/dt values measured at
other time points. This observation suggests that endogenous
ATP released during reperfusion following OGD causes a
transient inotropic effect on Langendorff-perfused mouse hearts
(Figures 2, 3C), which was associated with a considerable
increase in the maximum rate of contraction (+dP/dt) and
relaxation (-dP/dt) (Figure 4C).
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FIGURE 3 | Effects of apyrase and DPCPX added together or separately to the perfusion medium on left ventricular developed pressure (LVDP), measured before
(A) and at the end of 6-min oxygen-glucose deprivation (B), and at 2–5 min (C) and 10 min (D) after reperfusion (n = 4 for each group; using 16 mice in total).
*P < 0.05; N.S. = not significant.
DISCUSSION
We previously showed that the amount of ATP release, which is
largely mediated by the Maxi-Cl channel, is markedly enhanced
during 10-min reperfusion following a short period (6 min)
of perfusion with OGD (hypoxia) in the Langendorff-perfused
mouse heart model (Sabirov et al., 2017). The present study
investigated the functional effect of endogenous ATP on left
ventricular contractility by directly measuring the developed
pressure using exactly the same perfusion protocol in the
mouse heart. The LVDP gradually decreased during 6-min OGD,
which was followed by a transient increase in LVDP during
10-min reperfusion with oxygenated medium (Figure 2A).
These results are in accordance with a previous study showing
that LVDP is transiently increased over baseline levels during
reperfusion following a short period (90 s) of global ischemia
in Langendorff-perfused mouse hearts (Bratkovsky et al., 2004).
This transient inotropy was largely abolished under conditions
in which ATP degradation was facilitated by the extracellular
presence of apyrase and the adenosine A1 receptor was blocked
by DPCPX (Figure 2B). Furthermore, this transient inotropy
was similarly abolished by the presence of apyrase alone
(Figure 3C), indicating that this inotropic response was caused
by extracellular ATP. In contrast, the inotropic response was
scarcely affected by the presence of DPCPX alone (Figure 3C).
These results strongly suggest that a positive inotropy upon
reperfusion after a short-period of OGD is evoked by ATP itself
and is not due to the stimulation of adenosine A1 receptor
by adenosine produced by degradation of ATP. It should be
noted that the increase in ATP release during reperfusion is
transient, peaking at approximately 4 min after reperfusion [see
Figure 8C in Sabirov et al. (2017)]. Thus, the time course of
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FIGURE 4 | Effects of apyrase and DPCPX added together or separately to the perfusion medium on the rate of left ventricular pressure development (+dP/dt, upper
panel) and decline (-dP/dt, lower panel), measured before (A) and at the end of 6-min oxygen-glucose deprivation (B), and at 2–5 min (C) and 10 min (D) after
reperfusion (n = 4 in each group; using 16 mice in total). These data were obtained by analyzing the results presented in Figure 3. *P < 0.05; N.S. = not significant.
this transient increase in LVDP during reperfusion (Figure 2A)
is qualitatively similar to the time course of the transient
increase of ATP release, which largely occurs through the
Maxi-Cl channel (Sabirov et al., 2017). Taken together, it is
highly likely that the Maxi-Cl channel-mediated ATP release
contributes to the development of transient positive inotropy
during reperfusion following a short period of hypoxia in
the mouse heart.
Extracellular ATP has been recognized as a local regulator
of physiological functions in the cardiovascular system (Vassort,
2001; Burnstock and Pelleg, 2015). Extracellular ATP elicits
various cellular responses by binding to specific cell membrane
receptors, which can be divided into two major subfamilies,
namely P2X receptors, which constitute ligand-gated channels
and P2Y receptors, which are coupled to G-proteins and
downstream signaling molecules (Burnstock and Pelleg, 2015).
Several mechanisms have been proposed to explain the positive
inotropic action of ATP in the heart (Vassort, 2001). For
example, extracellular ATP enhances the L-type Ca2+ current
(Scamps et al., 1990), produces inositol-1,4,5-trisphosphate
(IP3) (Legssyer et al., 1988) and cyclic AMP (Balogh et al.,
2005), thereby activating the cardiac CFTR anion channels
(Matsuura and Ehara, 1992; Kaneda et al., 1994; Levesque
and Hume, 1995), or depolarizes the cell membrane through
activation of non-selective cation channels (Christie et al.,
1992). All these cellular processes can lead to elevation of
the intracellular free Ca2+ concentration [(Ca2+)i] and a
subsequent positive inotropic action of ATP in the heart
(Vassort, 2001).
The adenine nucleotides, ATP and ADP, are released from
various types of cells in the heart, including sympathetic
nerves, smooth muscles cells, blood cells and cardiac myocytes
(Clemens and Forrester, 1981; Gordon, 1986; Vassort, 2001;
Burnstock and Pelleg, 2015). Hypoxic conditions are regarded
as prominent activators of the ATP release in the heart
(Vassort, 2001). Evidence has been presented to support P2
purinoceptor-mediated cardioprotection during ischemia and
reperfusion. For example, the stimulation of P2Y2 receptors
with low concentrations of uridine triphosphate (UTP) improves
the recovery of the contractile function and reduces the
release of lactate dehydrogenase (LDH) during 45 min of
reperfusion after 20 min of global ischemia in the Langendorff-
perfused mouse heart model (Wee et al., 2007). It is also
interesting to note that UTP and uridine diphosphate (UDP)
produce positive inotropic effects on adult mouse cardiomyocytes
by activating P2Y2 and P2Y6 receptors, as evaluated by
stimulation-induced cell shortening (Wihlborg et al., 2006). It
thus seems probable that endogenous ATP released through
the Maxi-Cl channel contributes to a rapid recovery of
left ventricular contractile function (Figures 2–4) and thereby
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produces some protective effects on ischemia-reperfused hearts.
Furthermore, our findings that endogenous ATP produces
moderate positive inotropy may provide a clue for development
of new type of inotropic agents for clinical settings. The
present investigation represents an ischemia insult simulated by
perfusing the mouse heart with oxygen-glucose-deprived Tyrode
solution in situ. However, future studies should examine the
functional role of ATP release using ischemic conditions that can
occur in clinical conditions, such as occlusion of the coronary
artery in vivo.
In conclusion, our results provide the experimental evidence
supporting a possible role for endogenous ATP released through
the Maxi-Cl channel during reperfusion as a positive inotropic
factor for the heart.
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